SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarillion Plc Regulatory News (CLLN)

  • This share is currently suspended. It was suspended at a price of 14.27

Share Price Information for Carillion Plc (CLLN)

Share Price is delayed by 15 minutes
Get Live Data
14.27    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £61.40m
CLLN Live PriceLast checked at - London Stock Exchange

Intraday Carillion Plc Share Chart

Update

17 Nov 2017 07:02

RNS Number : 8037W
Carillion PLC
17 November 2017
 

17 November 2017

Update on discussions with stakeholders, trading and financial covenants deferral

Carillion plc ("Carillion" or "the Group") today provides an update on discussions with its financial stakeholders, trading and its intention to seek to defer the testing of its financial covenants.

Since July, the Group has been focused on reducing costs, collecting cash, executing its disposals programme and implementing its new operating model. These self-help measures will serve to reduce the Group's average net debt over time, but they will not be sufficient to enable the Group to achieve its target net debt to EBITDA ratio of between 1.0 to 1.5 times by the end of 2018. The Board is therefore in discussions with stakeholders regarding a broad range of options to further reduce net debt and repair and strengthen the Group's balance sheet. This will require some form of recapitalisation, which could involve a restructuring of the balance sheet. The Board expects to commence steps to implement the chosen option during the first quarter of 2018 and a further announcement will be made in due course.

In its interim results on 29 September 2017, Carillion confirmed that it was forecast to be in compliance with its financial covenants as at 31 December 2017. As then indicated, compliance with its financial covenants was dependent on achieving its underlying forecasts, which assume that the normal pattern of receipts and payments continue alongside the completion of a number of PPP disposals and settlement receipts on contracts.

The Board has kept under continuous review the risk that receipts from contract claims and/or disposals forecast to be received during November and December 2017 might slip beyond 31 December 2017. The Group now expects that a combination of delays to certain PPP disposals, a slippage in the commencement date of a significant project in the Middle East and lower than expected margin improvements across a small number of UK Support Services contracts, partially offset by cost savings initiatives realised in the fourth quarter, will lead to profits for the year to 31 December 2017 being materially lower than current market expectations. Given the impact of delays in receipts and disposals, the Group now expects full year average net borrowing in 2017 to be between £875m and £925m.

Based on its latest forecasts, reflecting the items mentioned above, the Board now expects a covenant breach as at 31 December 2017. Following discussions with its principal lenders and with their support, the Board has concluded that it is necessary to amend the relevant agreements to defer the test date for both its financial covenants from 31 December 2017 to 30 April 2018 (based on EBITDA for the 12 months to that date), by which time it expects to be implementing its recapitalisation plan. Carillion has now commenced a process to seek the consents necessary to make this amendment.

Commenting, Interim Chief Executive, Keith Cochrane said:

"Whilst we continue to target cash collections, reduce costs, execute disposals and focus on delivering for our customers, it is clear that significant challenges remain and more needs to be done to reduce net debt and rebuild the balance sheet. Constructive dialogue is continuing with our financial stakeholders, and I am grateful for their support. I remain focused on addressing this issue before my successor, Andrew Davies, takes up the role on 2 April 2018."

This and other Carillion news releases can be found at www.carillionplc.com.

 

For more information

Kellie McAvoy, Head of Investor Relations, or,

John Denning, Director Group Corporate Affairs, Carillion plc +44 (0) 1902 906333

 

 

 

Teneo Blue Rubicon

Fraser Hardie/Charles Armitstead/Haya Herbert-Burns +44 (0) 207 420 3197

 

Notes to editors

 

Financial covenants

Certain of Carillion's financing arrangements contain financial covenants that leverage (net debt / EBITDA) will be no more than 3.5 times and that interest cover (trading cashflow / net interest pre-IAS 19 charges) will be not less than 3.5 times.

 

Financing arrangements

The relevant financing arrangements are Carillion's senior additional funding facilities, syndicated revolving credit facility, private placement notes, Schuldschein loans, committed bonding lines and committed bilateral facilities.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAXFXFEEXFEF
Date   Source Headline
2nd Jul 20147:00 amRNSTrading Statement
19th Jun 20147:00 amRNSHighways Agency & Nottingham University Hospitals
17th Jun 201412:28 pmRNSDirector/PDMR Shareholding
17th Jun 20147:00 amRNSRe Contract
12th Jun 20147:00 amRNSAWP Route estimated to be in the region of £745m
9th Jun 201412:51 pmRNSDirectorate Change
9th Jun 20147:00 amRNSRe Contract
29th May 201410:20 amRNSDirector Declaration
22nd May 20147:00 amRNSMiddle East awarded contracts worth over £400m
16th May 20149:34 amRNSHolding(s) in Company
14th May 20142:34 pmRNSBlocklisting Interim Review
13th May 201412:30 pmRNSDirector/PDMR Shareholding
12th May 20148:07 amRNSRe Contract
12th May 20147:00 amRNSRe Contract
8th May 201410:43 amRNSAGM Statement
7th May 201412:19 pmRNSInterim Management Statement
16th Apr 20148:24 amRNSDirector Declaration
15th Apr 20148:32 amRNSHolding(s) in Company
11th Apr 201412:02 pmRNSDirector/PDMR Shareholding
11th Apr 20148:34 amRNSDirector/PDMR Shareholding
9th Apr 201410:09 amRNSDirector Declaration
31st Mar 20147:00 amRNSRe Contract
18th Mar 20147:00 amRNSRe Contract
5th Mar 20147:00 amRNSJV Middle East contract worth approx £150m
5th Mar 20147:00 amRNSSupport services contracts worth over £370 million
5th Mar 20147:00 amRNSFinal Results
27th Feb 20148:25 amRNSDirectorate Change
20th Feb 20147:00 amRNSDirectorate Change
13th Feb 20141:24 pmRNSDirectorate Change
12th Feb 20147:00 amRNSRe Contract
4th Feb 20147:41 amRNSCarillion JV appointed rail framework supplier
17th Dec 20134:21 pmRNSHolding(s) in Company
16th Dec 20137:00 amRNSFC £335 million Royal Liverpool Uni Hosp PPP
12th Dec 20134:50 pmRNSHolding(s) in Company
11th Dec 20137:02 amRNSContract extension with BT for Broadband Delivery
11th Dec 20137:00 amRNS2013 Pre-close Trading Update
29th Nov 20137:00 amRNSSunderland City Council programme £800m
12th Nov 20131:06 pmRNSBlocklisting Interim Review
11th Nov 20139:00 amRNSDirectorate Change
8th Nov 20137:52 amRNSDirector/PDMR Shareholding
7th Nov 201312:59 pmRNSDirector/PDMR Shareholding
1st Nov 201310:37 amRNSRe Contract
25th Oct 20139:42 amRNSHolding(s) in Company
14th Oct 20137:00 amRNSRe Contract
3rd Oct 20137:00 amRNSRe Contract
3rd Oct 20137:00 amRNSRe Contract
3rd Oct 20137:00 amRNSInterim Management Statement
27th Sep 20134:15 pmRNSDirector/PDMR Shareholding
25th Sep 20139:25 amRNSHolding(s) in Company
18th Sep 20134:36 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.